Heather Medwick
Fortuna: 2 750 $ al 31/05/2026
Fortuna: 2 750 $ al 31/05/2026
Heather Medwick served as President at Cytophage Technologies, Inc. (Old).
From 2024 to 2026, worked as Chief Operating Officer at Cytophage Technologies Ltd. Former jobs include President at Cytophage Technologies, Inc. (Old) and Chief Operating Officer at Cytophage Technologies Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/07/2025 | 687.500 ( 1,09 % ) | 2 750 $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| CYTOPHAGE TECHNOLOGIES LTD. | Presidente | - |
Cytophage Technologies, Inc. (Old)
Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Operates as a biotechnology company | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Cytophage Technologies, Inc. (Old)
Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cytophage Technologies Ltd.
Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.